A New Role for PHD in Chemotherapy

Rui hua Xu; Peng Huang

doi:10.1016/j.ccr.2012.07.013

A New Role for PHD in Chemotherapy

Rui hua Xu, Peng Huang

Translational Molecular Pathology

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Abstract

Enhancing therapeutic activity against cancer cells and minimizing toxic effects on normal cells are critical elements in chemotherapy. In this issue of Cancer Cell, Leite de Oliveira and colleagues reveal a previously unrecognized role of a prolyl hydroxylase domain in promoting drug delivery to tumors and reducing toxicity in normal organs.

Original language	English (US)
Pages (from-to)	143-144
Number of pages	2
Journal	Cancer cell
Volume	22
Issue number	2
DOIs	https://doi.org/10.1016/j.ccr.2012.07.013
State	Published - Aug 14 2012

ASJC Scopus subject areas

Oncology
Cell Biology
Cancer Research

Access to Document

10.1016/j.ccr.2012.07.013

Cite this

@article{5fd4619e1bf04dcaa9c469e7791b586b,

title = "A New Role for PHD in Chemotherapy",

abstract = "Enhancing therapeutic activity against cancer cells and minimizing toxic effects on normal cells are critical elements in chemotherapy. In this issue of Cancer Cell, Leite de Oliveira and colleagues reveal a previously unrecognized role of a prolyl hydroxylase domain in promoting drug delivery to tumors and reducing toxicity in normal organs.",

author = "Xu, {Rui hua} and Peng Huang",

year = "2012",

month = aug,

day = "14",

doi = "10.1016/j.ccr.2012.07.013",

language = "English (US)",

volume = "22",

pages = "143--144",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - A New Role for PHD in Chemotherapy

AU - Xu, Rui hua

AU - Huang, Peng

PY - 2012/8/14

Y1 - 2012/8/14

N2 - Enhancing therapeutic activity against cancer cells and minimizing toxic effects on normal cells are critical elements in chemotherapy. In this issue of Cancer Cell, Leite de Oliveira and colleagues reveal a previously unrecognized role of a prolyl hydroxylase domain in promoting drug delivery to tumors and reducing toxicity in normal organs.

AB - Enhancing therapeutic activity against cancer cells and minimizing toxic effects on normal cells are critical elements in chemotherapy. In this issue of Cancer Cell, Leite de Oliveira and colleagues reveal a previously unrecognized role of a prolyl hydroxylase domain in promoting drug delivery to tumors and reducing toxicity in normal organs.

UR - http://www.scopus.com/inward/record.url?scp=84865118056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865118056&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2012.07.013

DO - 10.1016/j.ccr.2012.07.013

M3 - Short survey

C2 - 22897845

AN - SCOPUS:84865118056

SN - 1535-6108

VL - 22

SP - 143

EP - 144

JO - Cancer cell

JF - Cancer cell

IS - 2

ER -

A New Role for PHD in Chemotherapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this